EPIDERMOLYSIS BULLOSA, DYSTROPHIC
Clinical trials for EPIDERMOLYSIS BULLOSA, DYSTROPHIC explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA, DYSTROPHIC trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA, DYSTROPHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gel could help heal wounds in rare skin disease
Disease control Recruiting nowThis study tests a gel called Oleogel-S10 on skin wounds in people with inherited epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. The trial includes 6 Japanese children and adults with junctional or dystrophic EB. Participants apply the gel to wounds…
Matched conditions: EPIDERMOLYSIS BULLOSA, DYSTROPHIC
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Does a Wound-Healing gel raise cancer risk? new study aims to find out
Knowledge-focused Recruiting nowThis study follows 580 people with dystrophic or junctional epidermolysis bullosa (EB) for up to 5 years. Researchers want to see if using Filsuvez, a birch bark extract gel that helps heal blisters, changes the risk of developing skin cancer. Participants receive standard care, …
Matched conditions: EPIDERMOLYSIS BULLOSA, DYSTROPHIC
Sponsor: Amryt Pharma • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:06 UTC